Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afatinib plus vinorelbine in HER2 2+ metastatic breast cancer after first-line failure
DRKS00003549Phase 2Terminated
- Sponsor
- University Hospital Magdeburg
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of afatinib, vinorelbine in breast cancer, sponsored by University Hospital Magdeburg. Started Feb 2012; status: terminated.
02
Drugs
afatinibvinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on DRKS00003549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003549.